Fungisiso yeStock yeKymera Therapeutics (KYMR)
AI forecast: KYMR
AI inoburitsa mutengo wechinangwa wezuva rinotevera rekutengesa, mugumo wevhiki uye mugumo wemwedzi. Shanduko inoyerwa kubva pamutengo wekupedzisira. Izvi zvinongova zvifungisiso zvehutano, hazviri mazano ekudyara.
Price over the last 6 months
Premium shows the AI's price targets for 1 day, 1 week and 1 month for this and every other stock.
Unlock Premium🔒 Nzira yekufungisisa
Nzira yekufungisisa — yese fungisiso yekare pamwe chete nekukwira kwazvino — ndiyo Premium.
Unlock PremiumNdiyi ya Kompani Iyi
Kymera Therapeutics, Inc. operates as a biopharmaceutical company focused on discovering and developing novel small-molecule therapeutics that selectively degrade disease-causing proteins by harnessing the body’s natural protein degradation machinery. Kymera Therapeutics serves customers in Massachusetts.